Why the study?
Are unfavorably altered fibrin clot properties associated with recurrent venous thromboembolism in medical patients following post-discharge events?
Are unfavorably altered fibrin clot properties associated with recurrent venous thromboembolism in medical patients following post-discharge events?
Altered fibrin clot properties may serve as a marker for recurrent venous thromboembolism risk in medical patients who experience post-discharge VTE.
Answers are grounded in this paper and cite their sources.
May flag high-risk medical patients for closer VTE surveillance; hypothesis-generating and requires prospective validation before clinical use.
RESEARCH LETTER Fibrin clots and recurrent thromboembolism 1 characteristic of patients with recurrent VTE who had a history of post -discharge VTE after hospitalization for an acute disease and stopped anticoagulation. Patients and methodsIn this case-control study patients were recruited at the John Paul II Hospital, Krakow, Poland, between October 2010 and June 2017.The design of the study was published previously. 5 In the current report, we assessed 2 age-and sex -matched groups of 48 adult patients who experienced VTE within 4 weeks of discharge from internal medicine wards.Exclusion criteria comprised age above 65 years, recent acute cardiovascular events, severe diseases (eg, cancer, end -stage kidney disease), and current anticoagulation.We compared follow -up data of the failed thromboprophylaxis group (acutely ill patients who developed post -discharge VTE despite thromboprophylaxis with low -molecular--weight heparins during the index hospital stay) and the non-thromboprophylaxis group (acutely ill patients without such thromboprophylaxis who experienced VTE within 4 weeks of discharge) reported previously. 5Causes of the index hospitalization included: exacerbation of asthma or chronic obstructive pulmonary disease, pneumonia, exacerbation of chronic heart failure, and relapse of rheumatic diseases (systemic lupus erythematosus, rheumatoid arthritis, and others).Detailed patient characteristics, definitions of comorbidities, and VTE risk factors were provided previously. 5 After at least 3 months of anticoagulation, blood samples were collected while off anticoagulation for coagulation assays.To characterize
No takes yet. Share an insight, caveat, or question.
Undas et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: